US drugmaker Pfizer and its German companion BioNTech have pledged to offer as much as 75 million extra doses of their vaccine to the EU within the second quarter of 2021, the German firm’s chief monetary officer Sierk Poetting stated on Monday.
“We are working with pharmaceutical companies to ensure vaccines are delivered to Europeans,” the Commission President, Ursula von der Leyen wrote in a Twitter submit, as on Sunday, she held a digital assembly with the CEOs of vaccine producers, throughout which, she burdened the necessity to watch out for the brand new Coronavirus variants.
The assembly, held the context of the bloc’s Vaccines Strategy, included BionNTech/Pfizer, Moderna, AstraZeneca, Johnson & Johnson, Curevac and Sanofi, with which, the EU has signed advance buy agreements (APA) for vaccines towards the virus.
“BioNTech/Pfizer will deliver 75 million of additional doses in the second quarter of the year – and up to 600 millions in total in 2021,” she added.
We are working with pharmaceutical firms to make sure vaccines are delivered to Europeans. #BioNTech/@pfizer will ship 75 million of further doses within the second quarter of the yr – and as much as 600 hundreds of thousands in complete in 2021.
— Ursula von der Leyen (@vonderleyen) February 1, 2021
The earlier day, British-Swedish pharmaceutical big AstraZeneca stated it’s going to ship to the European Union within the first quarter of this yr, 9 million extra doses of its COVID-19 vaccine developed together with Oxford University, bringing the overall quantity to 40 million for that interval.